Eyelid solution

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Available from:

Care Pharmaceuticals Pty Ltd

Class:

Class I

Manufactured by:

Schalcon Spa Via Di Saponara 614, Rome, 00125 Italy

Therapeutic area:

58837 - Eyelid solution

Therapeutic indications:

A liposomal phospholipid suspension intended to be applied to the eyelids for the treatment and relief of symptoms of dry, itchy and irritated eyes due to tear film deficiencies through the provision of supplemental lipids on the eyelid margin to stabilize the natural tear film lipid layer.

Authorization status:

A

Authorization date:

2014-12-01